Anna Locasciulli

Summary

Affiliation: San Camillo Hospital
Country: Italy

Publications

  1. pmc Hepatitis B and C in hematopoietic stem cell transplant
    Anna Locasciulli
    Pediatric Hematology Hematology Departments, San Camillo Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy
    Mediterr J Hematol Infect Dis 1:e2009016. 2009
  2. doi request reprint Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party
    Anna Locasciulli
    Ematologia Pediatrica e Trapianto di Midollo, Ospedale San Camillo, Roma, Italy
    Br J Haematol 149:890-5. 2010
  3. ncbi request reprint Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)
    Anna Locasciulli
    Ematologia e Trapianto di Midollo, Ospedale San Camillo, Circonvallazione Gianicolense 87, 00152 Roma Italy
    Haematologica 92:11-8. 2007
  4. ncbi request reprint Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma
    Ignazio Majolino
    Hematology and Bone Marrow Transplantation Unit, Azienda Ospedaliera S Camillo Forlanini, Rome, Italy
    Leuk Lymphoma 48:759-66. 2007
  5. ncbi request reprint Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study
    Anna Locasciulli
    Ematologia e Trapianto di Midollo, Ospedale San Camillo, Circonvallazione Gianicolense 87, 00152 Rome, Italy
    Haematologica 89:1054-61. 2004
  6. ncbi request reprint High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission
    Ignazio Majolino
    UO Ematologia e TMO, Azienda Ospedaliera S Camillo Forlanini, Roma, Italy
    Med Oncol 23:359-68. 2006
  7. ncbi request reprint Acquired aplastic anemia in children: incidence, prognosis and treatment options
    Anna Locasciulli
    Department of Hematology and Bone Marrow Transplantation, Ospedale San Camillo Forlanini, Rome, Italy
    Paediatr Drugs 4:761-6. 2002
  8. ncbi request reprint Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia
    Martin Stern
    University Hospital, Department of Hematology, Basel, Switzerland
    Transplantation 82:218-26. 2006
  9. ncbi request reprint Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT)
    Gerard Socie
    Service d Hématologie Greffe, and Institut National de la Santé et de la Recherche Médicale INSERM U728, Hospital Saint Louis, Paris, France
    Blood 109:2794-6. 2007
  10. ncbi request reprint Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT)
    Bernd Hertenstein
    Hannover Medical School, Department of Hematology and Oncology, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    Haematologica 90:969-75. 2005

Collaborators

Detail Information

Publications17

  1. pmc Hepatitis B and C in hematopoietic stem cell transplant
    Anna Locasciulli
    Pediatric Hematology Hematology Departments, San Camillo Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy
    Mediterr J Hematol Infect Dis 1:e2009016. 2009
    ..In case there is no alternative than a HBv or HCv positive geno-identical donor, the risk of viral hepatitis, including acute liver failure and late complications, should be balanced with the benefit of transplant in a given situation...
  2. doi request reprint Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party
    Anna Locasciulli
    Ematologia Pediatrica e Trapianto di Midollo, Ospedale San Camillo, Roma, Italy
    Br J Haematol 149:890-5. 2010
    ..In conclusion, the incidence of HAA was 5% and was evenly distributed over time and geographic areas in Europe. Treatment outcome and predictive variables, were comparable in patients with or without HAA...
  3. ncbi request reprint Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)
    Anna Locasciulli
    Ematologia e Trapianto di Midollo, Ospedale San Camillo, Circonvallazione Gianicolense 87, 00152 Roma Italy
    Haematologica 92:11-8. 2007
    ..The aim of this study was to assess the outcome of children and adults with AA treated in the last decade, and to determine whether results have improved in two sequential time periods,1991-1996 and 1997-2002...
  4. ncbi request reprint Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma
    Ignazio Majolino
    Hematology and Bone Marrow Transplantation Unit, Azienda Ospedaliera S Camillo Forlanini, Rome, Italy
    Leuk Lymphoma 48:759-66. 2007
    ..When used as first line treatment the results of transplantation appear even more encouraging...
  5. ncbi request reprint Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study
    Anna Locasciulli
    Ematologia e Trapianto di Midollo, Ospedale San Camillo, Circonvallazione Gianicolense 87, 00152 Rome, Italy
    Haematologica 89:1054-61. 2004
    ..The aim of the present study was to test whether a higher dose of G-CSF (10 micro g/kg/day) would reduce these complications...
  6. ncbi request reprint High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission
    Ignazio Majolino
    UO Ematologia e TMO, Azienda Ospedaliera S Camillo Forlanini, Roma, Italy
    Med Oncol 23:359-68. 2006
    ..However, the addition of autograft was not usually feasible and of questionable clinical use. Other strategies should thus be considered for remission maintenance...
  7. ncbi request reprint Acquired aplastic anemia in children: incidence, prognosis and treatment options
    Anna Locasciulli
    Department of Hematology and Bone Marrow Transplantation, Ospedale San Camillo Forlanini, Rome, Italy
    Paediatr Drugs 4:761-6. 2002
    ..Therefore, patients should be referred to experienced centers early in the course of the disease in order to offer the patient the best therapeutic options presently available...
  8. ncbi request reprint Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia
    Martin Stern
    University Hospital, Department of Hematology, Basel, Switzerland
    Transplantation 82:218-26. 2006
    ..An increased rejection of male grafts in female recipients is not reported for solid organ or stem cell transplants and the role of H-Y as transplantation antigen has been controversial...
  9. ncbi request reprint Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT)
    Gerard Socie
    Service d Hématologie Greffe, and Institut National de la Santé et de la Recherche Médicale INSERM U728, Hospital Saint Louis, Paris, France
    Blood 109:2794-6. 2007
    ..These results emphasize the necessity of the current European randomized trial comparing IST with or without G-CSF and to alert physicians that adding G-CSF to IST is currently not standard treatment for SAA...
  10. ncbi request reprint Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT)
    Bernd Hertenstein
    Hannover Medical School, Department of Hematology and Oncology, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    Haematologica 90:969-75. 2005
    ..DCL is an extremely rare complication of allogeneic SCT in which treatment attempts with chemotherapy and a second SCT are justified. Donors are not at an increased risk of developing hematologic malignancies...
  11. pmc Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
    Hubert Schrezenmeier
    Institute of Clinical Transfusion Medicine and Immunogenetics, University of Ulm, Germany
    Blood 110:1397-400. 2007
    ..Corresponding probabilities for older patients were 52% and 64%. These data indicate that BM grafts are preferred to PBPC grafts in young patients undergoing HLA-matched sibling donor transplantation for SAA...
  12. ncbi request reprint Nonmalignant late effects after allogeneic stem cell transplantation
    Gerard Socie
    Hematology Stem Cell Transplantation, Hopital Saint Louis, Paris, France
    Blood 101:3373-85. 2003
  13. doi request reprint Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up
    Paola Saracco
    Paediatric Haematology, University of Turin, Turin, Italy
    Br J Haematol 140:197-205. 2008
    ..This long-term follow-up of children with AAA shows that IST with a slow CyA tapering course is an effective treatment with a low-relapse rate in these cases...
  14. pmc Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party
    Debra L Friedman
    Fred Hutchinson Cancer Research Center, University of Washington, Seattle 98109, USA
    Blood 111:939-44. 2008
    ..Hazard for death associated with breast cancer was 2.5 (95% CI: 1.1-5.8). We conclude that female survivors of allogeneic HCT are at increased risk of breast cancer and should be educated about the need for regular screening...
  15. ncbi request reprint Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling
    Albert N Bekassy
    Pediatr Blood Cancer 45:359-60; author reply 361-2. 2005
  16. ncbi request reprint Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients
    Carlo Dufour
    Hematology Unit, Department of Pediatric Hemato Oncology, Giannina Gaslini Children s Hospital, Genoa, Italy
    Haematologica 90:1027-31. 2005
    ..We assessed whether, in a Caucasian population, low or null activity polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 were associated with the risk of developing aplastic anemia and with the response to immunosuppressive therapy...
  17. ncbi request reprint Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin
    Maria Teresa Van Lint
    Divisione Ematologia 2, Ospedale San Martino, 16132 Genoa, Italy
    Blood 107:4177-81. 2006
    ....